Birabresib Dose 20 mg: Clinical Trials

1 terminated. 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	1	Terminated 1

Follow Birabresib Dose 20 mg: new trials by email Literature Review of Birabresib Dose 20 mg trials Research Report on Birabresib Dose 20 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005) Birabresib Dose 20 mg - AML Including AML de Novo and AML Secondary to MDS, DLBCL	Phase 1	Terminated	Merck Sharp & Dohme LLC	9	2016-05-19	2022-09-13

Sponsors

Merck Sharp & Dohme LLC (1)

NIH funding

2015 (1)